According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ2.51. In 2022 the company made an earnings per share (EPS) of -ยฃ2.97 a decrease over its 2021 EPS that were of -ยฃ2.12.